Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol
Abstract Background The optimal duration of anticoagulation after a first unprovoked venous thromboembolism (VTE) remains controversial. Deciding to stop or continue anticoagulant therapy indefinitely after completing 3 to 6 months of initial treatment requires balancing the long-term risk of recurr...
Main Authors: | Faizan Khan, Miriam Kimpton, Tobias Tritschler, Grégoire Le Gal, Brian Hutton, Dean A. Fergusson, Marc A. Rodger |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Systematic Reviews |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13643-019-1175-5 |
Similar Items
-
Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
by: Ramón Lecumberri, et al.
Published: (2021-07-01) -
Bleeding and venous thromboembolism events in cancer patients taking direct oral anticoagulants vs. low molecular weight heparin
by: Frank A. Lattuca, et al.
Published: (2023-03-01) -
D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
by: Håkon S. Johnsen, et al.
Published: (2019-01-01) -
Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk
by: Viktoria Muster, et al.
Published: (2021-06-01) -
Oral anticoagulants: Optimizing venous thromboembolism management
by: Fahad A S. Aleidan
Published: (2019-01-01)